Houlihan Lokey
HLI NYSE Investment Banking & Brokerage Financials FY2017βFY2026
Houlihan Lokey's revenue rose 9.6% to $2.6 billion in fiscal 2026. Its operating margin was 20.1%, down from 21.0% a year earlier. Free cash flow was $682 million, down 15.7%. It paid out $349 million in dividends and buybacks, 51% of free cash flow. The diluted share count fell 0.3%.
About these figures. Gross margin for fiscal 2026 is blank: the 10-K's structured data doesn't include every figure it needs. Interest coverage for fiscal 2026 is blank: the 10-K's structured data has no interest expense for that year.
What Houlihan Lokey does
No business description yet.
- Legal name
- HOULIHAN LOKEY, INC.
- Fiscal year ends
- March 31, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001302215-26-000053
0001302215
Revenue and margins
Houlihan Lokey had $2.6B of revenue in fiscal 2026, up 9.6% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 16.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $682M in fiscal 2026, 26.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Houlihan Lokey returned $349M to shareholders in fiscal 2026, 51% of free cash flow. The diluted share count fell 0.3%.
Value Houlihan Lokey yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β and divides by 68.4M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 22.0x Β· peers 21.5x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Houlihan Lokey can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $834M | $714M | $721M | $971M | $1.2B |
| Interest coverage | 612.9x | 57.9x | 644.6x | 368.7x | β |
| Total assets | $2.9B | $3.0B | $3.2B | $3.8B | $4.3B |
| Total liabilities | $1.4B | $1.4B | $1.3B | $1.6B | $1.9B |
| Shareholders' equity | $1.4B | $1.6B | $1.8B | $2.2B | $2.3B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.5M
1 insider
Sold, 12 months
$2.1M
3 insiders
Of sales under plans
8%
$0.2M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Christopher M CrainGeneral Counsel | Sold | 1,000 | $140.15 | $0.1M | Form 4 |
| Aug 3, 2026 | Alley J LindseyChief Financial Officer | Bought | 4,020 | $124.52 | $0.5M | Form 4 |
| May 21, 2026 | Scott L BeiserCo-chairman, Director, 10% owner | Sold | 6,265 | $150.26 | $0.9M | Form 4 |
| Apr 1, 2026 | Christopher M CrainGeneral Counsel | Sold plan | 500 | $143.40 | $0.1M | Form 4 |
| Feb 6, 2026 | Robert A SchriesheimDirector | Sold | 5,000 | $170.86 | $0.9M | Form 4 |
| Jan 2, 2026 | Christopher M CrainGeneral Counsel | Sold plan | 500 | $174.17 | $0.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β1.6% | β12.8% | β6.9% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Houlihan Lokey HLI | $8.9B | 9.6% | 20.1% | 26.1% | β | 22.0x | β | |
| BGC Group BGC | $5.6B | 30.0% | β | 12.7% | 13.2% | 28.8x | β | Compare β |
| Virtu Financial VIRT | $4.9B | 26.3% | β | 13.6% | 37.9% | 9.3x | β | Compare β |
| Evercore EVR | $10.4B | 29.5% | β | 30.5% | β | 14.2x | 5 | Compare β |
| Robinhood HOOD | $86.7B | 51.6% | β | 36.3% | β | 41.9x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $872M | $963M | $1.1B | $1.2B | $1.5B | $2.3B | $1.8B | $1.9B | $2.4B | $2.6B |
| Gross profit | $242M | $278M | $306M | $323M | $521M | $795M | $557M | $571M | $772M | β |
| Operating income | $182M | $214M | $219M | $230M | $408M | $613M | $342M | $373M | $503M | $527M |
| Interest expense | $1.6M | $0.7M | $1.0M | $1.0M | $1.0M | $1.0M | $5.9M | $0.6M | $1.4M | β |
| Pretax income | $179M | $218M | $224M | $236M | $409M | $604M | $324M | $391M | $531M | $562M |
| Income tax | $70.1M | $45.6M | $65.2M | $51.9M | $96.5M | $166M | $69.8M | $110M | $132M | $138M |
| Net income | $108M | $172M | $159M | $184M | $313M | $438M | $254M | $280M | $400M | $426M |
| Diluted EPS | $1.63 | $2.60 | $2.42 | $2.80 | $4.55 | $6.41 | $3.76 | $4.11 | $5.82 | $6.22 |
| Diluted shares | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B |
| Cash flow | ||||||||||
| Cash from operations | $252M | $251M | $224M | $288M | $580M | $737M | $136M | $329M | $849M | $704M |
| Capital expenditure | $14.4M | $7.7M | $6.7M | $20.7M | $14.1M | $8.7M | $50.7M | $66.7M | $39.7M | $22.3M |
| Free cash flow | $238M | $243M | $218M | $267M | $566M | $728M | $85.5M | $262M | $809M | $682M |
| Depreciation and amortization | $8.9M | $7.9M | $14.5M | $17.3M | $15.2M | $48.5M | $58.2M | $28.5M | $41.3M | $42.6M |
| Stock-based compensation | $39.4M | $47.1M | $56.6M | $64.3M | $62.4M | $91.9M | $157M | $167M | $168M | $201M |
| Acquisitions | $3.7M | $2.7M | $71.4M | $2.2M | $12.5M | $361M | $20.4M | $3.9M | $69.2M | $2.5M |
| Share buybacks | $0.0M | $18.1M | $69.6M | $29.6M | $102M | $305M | $48.7M | $25.0M | $52.5M | $175M |
| Dividends paid | $55.3M | $52.1M | $66.9M | $80.7M | $92.0M | $115M | $140M | $149M | $165M | $174M |
| Dividends and buybacks | $55.3M | $70.2M | $136M | $110M | $194M | $420M | $189M | $173M | $218M | $349M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $300M | $207M | $286M | $380M | $847M | $834M | $714M | $721M | $971M | $1.2B |
| Total debt | $32.6M | $11.9M | $31.2M | $36.7M | $55.9M | β | β | β | β | β |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $30.4M | $32.1M | $31.0M | $42.4M | $46.4M | $52.2M | $88.3M | $137M | $149M | $143M |
| Total assets | $1.4B | $1.4B | $1.4B | $1.7B | $2.4B | $2.9B | $3.0B | $3.2B | $3.8B | $4.3B |
| Total liabilities | $655M | $566M | $535M | $693M | $1.0B | $1.4B | $1.4B | $1.3B | $1.6B | $1.9B |
| Shareholders' equity | $727M | $853M | $891M | $984M | $1.4B | $1.4B | $1.6B | $1.8B | $2.2B | $2.3B |
| Margins | ||||||||||
| Gross margin | 27.7% | 28.8% | 28.2% | 27.8% | 34.2% | 35.0% | 30.8% | 29.8% | 32.3% | β |
| Operating margin | 20.9% | 22.3% | 20.2% | 19.8% | 26.8% | 27.0% | 18.9% | 19.5% | 21.0% | 20.1% |
| EBITDA margin | 21.9% | 23.1% | 21.5% | 21.3% | 27.8% | 29.1% | 22.1% | 21.0% | 22.8% | 21.8% |
| Net margin | 12.4% | 17.9% | 14.7% | 15.9% | 20.5% | 19.3% | 14.1% | 14.6% | 16.7% | 16.3% |
| FCF margin | 27.2% | 25.2% | 20.1% | 23.0% | 37.1% | 32.1% | 4.7% | 13.7% | 33.9% | 26.1% |
| Returns | ||||||||||
| Return on capital | 21.7% | 30.4% | 24.0% | 28.0% | 50.6% | β | β | β | β | β |
| Return on equity | 15.7% | 21.8% | 18.2% | 19.6% | 26.4% | 31.0% | 16.6% | 16.3% | 19.9% | 18.9% |
| Return on assets | 8.8% | 12.3% | 11.2% | 11.9% | 15.3% | 16.5% | 8.7% | 9.1% | 11.4% | 10.5% |
| Growth | ||||||||||
| Revenue growth | β | 10.5% | 12.6% | 6.9% | 31.6% | 48.8% | β20.3% | 5.8% | 24.8% | 9.6% |
| Net income growth | 55.4% | 59.0% | β7.7% | 15.5% | 70.2% | 40.0% | β41.9% | 10.3% | 42.6% | 6.5% |
| EPS growth | 48.2% | 59.5% | β6.9% | 15.7% | 62.5% | 40.9% | β41.3% | 9.3% | 41.6% | 6.9% |
| FCF growth | 10,071.1% | 2.2% | β10.5% | 22.7% | 111.9% | 28.7% | β88.3% | 206.0% | 209.1% | β15.7% |
| Share count change | 4.9% | β0.4% | β0.7% | β0.2% | 4.5% | β0.6% | β1.0% | 0.9% | 0.7% | β0.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | β1.4x | β0.9x | β1.1x | β1.4x | β1.9x | β | β | β | β | β |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | β | β | β | β | β |
| Interest coverage | 112.3x | 326.9x | 224.3x | 218.9x | 412.7x | 612.9x | 57.9x | 644.6x | 368.7x | β |
| Capital allocation | ||||||||||
| Capex / revenue | 1.7% | 0.8% | 0.6% | 1.8% | 0.9% | 0.4% | 2.8% | 3.5% | 1.7% | 0.9% |
| Stock comp / revenue | 4.5% | 4.9% | 5.2% | 5.6% | 4.1% | 4.1% | 8.7% | 8.7% | 7.1% | 7.7% |
| Payouts / FCF | 23.3% | 28.9% | 62.7% | 41.3% | 34.3% | 57.6% | 221.0% | 66.3% | 26.9% | 51.3% |
| Quality scores | ||||||||||
| Accruals ratio | β11.7% | β5.6% | β4.6% | β6.7% | β13.0% | β11.3% | 4.0% | β1.6% | β12.8% | β6.9% |
Source: SEC EDGAR XBRL filings (CIK 0001302215). Data updated October 18, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.